To specifically deliver recombinant HP-NAP to the tissue of concern and provide controlled release therapy, chitosan nanoparticles were used as the carriers for recombinant HP-NAP and this nanoparticle-protein complex was applied in a mouse xenograft model with breast cancer. This evidence concerns the gene HP and breast carcinoma.